Advanced Health Intelligence Ltd
Change company Symbol lookup
Select an option...
AHI Advanced Health Intelligence Ltd
SNTG Sentage Holdings Inc
MDGS Medigus Ltd
WLDS Wearable Devices Ltd
UP Wheels Up Experience Inc
BRTX BioRestorative Therapies Inc
FRZA Forza X1 Inc
ILMN Illumina Inc
NR Newpark Resources Inc
CGC Canopy Growth Corp

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Health Care Technology | Small Cap Blend
Based in Australia
Company profile

Advanced Human Imaging Limited is an Australia-based human imaging company. The Company offers a smartphone-based human scanning technology, with a range of data-driven applications across multiple industries. It has developed a dimensioning technology that enables its partners and their users to check, track, and assess their vital signs and dimensions using only a smartphone. Its CompleteScan platform is a multi-scan technology for its partner's smartphone application users. Its BodyScan technology is an image processing technique that returns body circumference, body composition, health risks, and risk indicators. Its FaceScan technology is a non-intrusive method for measuring vital signs, and risks associated with cardiovascular disease, heart attack and stroke. Its DermaScan technology is an intelligent, instant dermatological scanner with diagnostic capabilities, capable of screening for over 500 skin conditions. The Company offers its solutions to various industries.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Closing Price
Day's Change
1.87 (603.23%)
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:

Fisker stock surges nearly 30% as EV maker closer to marketing key electric SUV

12:26 pm ET February 27, 2023 (MarketWatch)

By Tomi Kilgore and Claudia Assis

Ocean's announcement a 'major step' in Fisker's journey

Fisker Inc. shares jumped nearly 30% Monday after the electric-vehicle maker reported a wider-than-expected loss and revenue that came up short, but maintained its 2023 production targets and said it was close to being able to sell a key EV.

Fisker (FSR) reported a loss of $170.1 million, or 54 cents a share, compared with a loss of $138.4 million, or 47 cents a share, in the year-ago period. Revenue rose to $306,000 from $41,000.

The FactSet consensus was for a loss of 41 cents a share on revenue of $1.1 million. The company said it had over $736 million in cash at the end of 2022, which was more than expected.

See also:Elon Musk to unveil Tesla's 'Master Plan 3' on Wednesday's investor day -- here's what to expect

Investors looked past the missed expectations, however, to focus on Fisker's announcement that the electric luxury SUV Fisker Ocean is on track to be homologated, or cleared for sale, in March, with first deliveries happening "shortly after."

That's "a major step in an expected long journey of necessary execution for Fisker," Chris McNally at Evercore ISI said in a note Monday.

"This stock must now go from 'concept' in the mind of investors (high skepticism), to reality, with the burden of proof moving to Fisker's ability to show they can deliver on targets and business model," including driving "significant" demand for the Ocean and earn a "strong" return on total capital through its model of contract manufacturing, the analyst said.

Don't miss:Lucid stock falls 18% as investors see takeover risk

Fisker said it still expects to produce 42,400 vehicles in 2023, and expects total expenses of $535 million to $610 million, which is less than 2022 total spending of $702 million.

The stock has tumbled 24.1% over the past three months through Friday, while the S&P 500 index has lost 1.4%. In a year's time, Fisker shares have lost about 37%, compared with a decline of about 9% for the S&P 500.

-Tomi Kilgore


(END) Dow Jones Newswires

February 27, 2023 12:26 ET (17:26 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.